News & Insights
The latest in Chinese medical innovation, treatment breakthroughs, and policy updates for international patients.
China's Special Medical Zone -- With New Drugs and Treatments for Patients
Boao Lecheng International Medical Tourism Pilot Zone is China's only government-designated "medical special zone". It has faster access to globally approved drugs, advanced medical devices, and breakthrough treatments. It could be months or years ahead of standard mainland availability.
China's Innovative Drug Approvals Hit a Record High in 2025
A record number of innovative medicines reached patients in China in 2025, expanding treatment options for international patients seeking advanced therapies across oncology, autoimmune disease, and chronic conditions.
World-Leading Medical Institutions Are Putting Down Roots in China
International medical centers are establishing representative offices and research partnerships in China, bringing world-class diagnostics, second opinions, and cross-border care closer to patients.
More International Patients Are Choosing China for Planned Medical Care
Visa-free transit policies and rising confidence in Chinese healthcare are drawing a more diverse group of international patients — and shifting medical travel from emergency-only visits to planned, elective care.
China Opens Three New Proton Therapy Centers, Cutting Wait Times
The expansion of proton therapy capacity in China offers international patients faster access to this precise radiation treatment.
China Approves Two New CAR-T Therapies, Expanding Access for International Patients
China's NMPA approved two new CAR-T cell therapy products in 2024, bringing the country's total to six — among the most of any country.
New Biologic Therapies Expand Treatment Options for Lupus Patients in China
International patients with systemic lupus erythematosus can now access innovative targeted biologic treatments at leading hospitals in China, including therapies introduced through the Greater Bay Area's cross-border drug access policy.
Greater Bay Area Expands Cross-Border Access to Innovative Drugs and Medical Devices
China's 'Hong Kong and Macao Drug and Device Connect' policy now covers more designated hospitals, giving international patients faster access to innovative medicines and devices already approved in Hong Kong and Macao.